Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs
- PMID: 39731910
- PMCID: PMC11735314
- DOI: 10.1016/j.immuni.2024.12.003
Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs
Abstract
Innate-like splenic marginal zone (MZ) B (MZB) cells play unique roles in immunity due to their rapid responsiveness to blood-borne microbes. How MZB cells integrate cell-extrinsic and -intrinsic processes to achieve accelerated responsiveness is unclear. We found that Delta-like1 (Dll1) Notch ligands in splenic fibroblasts regulated MZB cell pool size, migration, and function. Dll1 could not be replaced by the alternative Notch ligand Dll4. Dll1-Notch2 signaling regulated a Myc-dependent gene expression program fostering cell growth and a Myc-independent program controlling cell-movement regulators such as sphingosine-1 phosphate receptor 1 (S1PR1). S1pr1-deficient B cells experienced Notch signaling within B cell follicles without entering the MZ and were retained in the spleen upon Notch deprivation. Key elements of the mouse B cell Notch regulome were preserved in subsets of human memory B cells and B cell lymphomas. Thus, specialized niches program the poised state and patrolling behavior of MZB cells via conserved Myc-dependent and Myc-independent Notch2-regulated mechanisms.
Keywords: B cells; Notch; chemotaxis; fibroblastic reticular cells; marginal zone; spleen.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests S.K. is currently employed by Century Therapeutics; L.C. by Interius BioTherapeutics; D.G.A. by Aro Biotherapeutics; and C.W.S by Gilead Sciences. L.M. is a current and C.W.S. a former employee of Genentech. I.M. has received research funding from Genentech and Regeneron and is a member of Garuda Therapeutics’s scientific advisory board.
References
-
- Martin F, Oliver AM, and Kearney JF (2001). Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14, 617–629. - PubMed
-
- Oliver AM, Martin F, and Kearney JF (1999). IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 162, 7198–7207. - PubMed
-
- Gaudette BT, Roman CJ, Ochoa TA, Gomez Atria D, Jones DD, Siebel CW, Maillard I, and Allman D (2021). Resting innate-like B cells leverage sustained Notch2/mTORC1 signaling to achieve rapid and mitosis-independent plasma cell differentiation. J Clin Invest 131. 10.1172/JCI151975. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
- T32 AI055428/AI/NIAID NIH HHS/United States
- KL2 TR001879/TR/NCATS NIH HHS/United States
- T32 CA009140/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- T32 GM007863/GM/NIGMS NIH HHS/United States
- R01 HL159175/HL/NHLBI NIH HHS/United States
- R21 AI174069/AI/NIAID NIH HHS/United States
- R01 AI175185/AI/NIAID NIH HHS/United States
- R01 CA278976/CA/NCI NIH HHS/United States
- R01 CA271455/CA/NCI NIH HHS/United States
- T32 HL007439/HL/NHLBI NIH HHS/United States
- R01 AI139123/AI/NIAID NIH HHS/United States
- T32 AI070077/AI/NIAID NIH HHS/United States
- R01 AI091627/AI/NIAID NIH HHS/United States
- R01 CA228135/CA/NCI NIH HHS/United States
- R01 CA283574/CA/NCI NIH HHS/United States
- R21 AI161931/AI/NIAID NIH HHS/United States
- F30 AI161873/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous